Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
VYGR
#2924
Voyager Therapeutics, Inc. Common Stock
4.100
0
+0.12%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
+0.12%
Monatliche Änderung
+4.06%
6 month change
-11.83%
Jahresänderung
-11.83%
Vorheriger Schlusskurs
4.095
0
Open
4.100
0
Bid
Ask
Low
4.100
0
High
4.100
0
Volumen
37
Märkte
Aktien
Gesundheitswesen
VYGR
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
54.63 M
55.21 M
55.34 M
55.47 M
55.6 M
—
Valuation ratios
Enterprise value
207.03 M
241.66 M
112.28 M
128.57 M
214.53 M
697.03 M
Price to earnings ratio
9.59
-5.02
-2.35
-1.69
-2.16
-11.22
Price to sales ratio
1.77
4.09
2.92
4.23
8.69
19.93
Price to cash flow ratio
-11.52
21.36
-33.08
3.07
2.34
-6.31
Price to book ratio
0.26
1.09
0.16
0.16
0.26
1.67
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.02
0.09
0.09
0.1
0.1
0.38
Return on equity %
0.03
0.12
0.11
0.14
0.13
0.49
Return on invested capital %
66.85
130.88
97.47
113.11
116.47
457.92
Gross margin %
100
100
100
100
100
400
Operating margin %
56.02
607.82
533.74
704.33
228.31
2 074.2
EBITDA margin %
—
—
—
—
—
—
Net margin %
36.76
547.33
477.25
641.96
208.15
1 874.68
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
8.45
5.56
6.1
5.43
6.19
23.27
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.06
0.02
0.02
0.02
0.04
0.09
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.46
0.25
0.65
0.57
0.53
2
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
5.97
5.76
5.06
4.47
3.89
19.18
Net current asset value per share
6.46
4.8
4.2
3.88
3.73
16.62
Tangible book value per share
5.71
5.2
4.67
4.16
3.74
17.77
Working capital per share
5.69
3.94
3.51
3.17
3.13
13.75
Book value per share
5.71
5.2
4.67
4.16
3.74
17.77
Nachrichten
Fortrea Holdings Inc. (FTRE) Q4 Earnings and Revenues Lag Estimates
Alzheimer's Clinical Trial Results, Sadly Running True To Form
J&J Halts Alzheimer's Trial After Drug Fails To Slow Clinical Decline - Johnson & Johnson (NYSE:JNJ)
H.C. Wainwright senkt Kursziel für Voyager Therapeutics auf 25 US-Dollar/n
Voyager Therapeutics stock price target lowered to $25 at H.C. Wainwright
Voyager Therapeutics: Strategie-Update zu Gentherapien für neurodegenerative Erkrankungen
Voyager Therapeutics at Stifel Conference: Neurotherapeutic Innovations
Leerink Partners hebt Kursziel für Voyager Therapeutics auf 12 US-Dollar an
Voyager Therapeutics stock price target raised to $12 by Leerink Partners
Voyager Therapeutics Inc: EPS übertrifft Schätzungen um 0,05 $ - Umsatz besser als erwartet
Voyager Therapeutics Inc earnings beat by $0.05, revenue topped estimates
Voyager Therapeutics (VYGR) Reports Q3 Loss, Tops Revenue Estimates